General
Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down following a plunge in the company’s share price, the drug maker said on Friday.
The company said it was searching for a successor for Lars Fruergaard Jorgensen, who has held the…
Continue Reading
-
General19 hours agoAustralian Oscar Jenkins sentenced to 13 years in jail by Russia for fighting alongside Ukrainian forces
-
Noosa News23 hours agoQueensland’s most dangerous roads for motorcyclists revealed
-
General24 hours agoBrian John Leering jailed for 2022 rape of woman in White Gum Park, Kununurra
-
General23 hours agoSydney vs Carlton AFL round 10 live blog: Swans host Blues at SCG in desperate need of a win